Clathrin-Mediated Endocytosis Is Required for Compensatory Regulation of GLR-1 Glutamate Receptors after Activity Blockade
Chronic changes in neural activity trigger a variety of compensatory homeostatic mechanisms by which neurons maintain a normal level of synaptic input. Here we show that chronic activity blockade triggers a compensatory change in the abundance of GLR-1, a Caenorhabditis elegans glutamate receptor. I...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 101; no. 9; pp. 3190 - 3195 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
02.03.2004
National Acad Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Chronic changes in neural activity trigger a variety of compensatory homeostatic mechanisms by which neurons maintain a normal level of synaptic input. Here we show that chronic activity blockade triggers a compensatory change in the abundance of GLR-1, a Caenorhabditis elegans glutamate receptor. In mutants lacking a voltage-dependent calcium channel (unc-2) or a vesicular glutamate transporter (VGLUT; eat-4), the abundance of GLR-1 in the ventral nerve cord was increased. Similarly, the amplitude of glutamate-evoked currents in ventral cord interneurons was increased in eat-4 VGLUT mutants compared with wild-type controls. The effects of eat-4 VGLUT mutations on GLR-1 abundance in the ventral cord were eliminated in double mutants lacking both the clathrin adaptin protein unc-11 AP180 and eat-4 VGLUT. In contrast, mutations that decreased ubiquitination of GLR-1 did not prevent increased ventral cord abundance of GLR-1 in eat-4 VGLUT mutants. Taken together, our results suggest that GLR-1 is regulated in a homeostatic manner and that this effect depends on clathrin-mediated endocytosis but does not require ubiquitination of GLR-1. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 Abbreviations: GluR, glutamate receptor; VDCC, voltage-dependent calcium channel; VGLUT, vesicular glutamate transporter; AMPA, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; NMDA, N-methyl-d-aspartate. Present address: Institute for Neurodegenerative Disease, Massachusetts General Hospital, Harvard Medical School, 114 16th Street, Charlestown, MA 02129. This paper was submitted directly (Track II) to the PNAS office. To whom correspondence should be addressed at: Department of Molecular Biology, Massachusetts General Hospital, Wellman 8, 50 Blossom Street, Boston, MA 02114. E-mail: kaplan@molbio.mgh.harvard.edu. Edited by Corey S. Goodman, Renovis, South San Francisco, CA, and approved January 9, 2004 Present address: Institute of Physiology I, University of Tübingen, Gmelinstrasse 5, D-72076 Tübingen, Germany. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.0306156101 |